209 related articles for article (PubMed ID: 8450836)
1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
[TBL] [Abstract][Full Text] [Related]
2. Identification of a specific binding site for K+ channel openers in rat aorta.
Ouast U; Bray KM; Baumlin Y; Andres H; Manley PW
Jpn J Pharmacol; 1992; 58 Suppl 2():226P-231P. PubMed ID: 1507537
[TBL] [Abstract][Full Text] [Related]
3. K-channel opening activity of dihydropyridine ZM244085: effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle.
Trivedi S; Potter-Lee L; McConville MW; Li JH; Ohnmacht CJ; Trainor DA; Kau ST
Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):137-51. PubMed ID: 7670846
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by protein kinase C of the 86Rb+ efflux and vasorelaxation induced by P1075, a K(ATP) channel opener, in rat isolated aorta.
Linde C; Löffler C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):425-32. PubMed ID: 9303583
[TBL] [Abstract][Full Text] [Related]
5. Interaction between thiol-modifying agents and P1075, a K(ATP) channel opener, in rat isolated aorta.
Linde C; Löffler C; Kessler C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):467-74. PubMed ID: 9349633
[TBL] [Abstract][Full Text] [Related]
6. Binding of K(ATP) channel modulators in rat cardiac membranes.
Löffler-Walz C; Quast U
Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
Linde C; Quast U
Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466
[TBL] [Abstract][Full Text] [Related]
8. Tissue and species variation in the vascular receptor binding of 3H-P1075, a potent KATP opener vasodilator.
Higdon NR; Khan SA; Buchanan LV; Meisheri KD
J Pharmacol Exp Ther; 1997 Jan; 280(1):255-60. PubMed ID: 8996204
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
10. K-channel opening activity of ZD6169 and its analogs: effect on 86Rb efflux and 3H-P1075 binding in bladder smooth muscle.
Trivedi S; Stetz SL; Potter-Lee L; McConville M; Li JH; Empfield J; Ohnmacht CJ; Russell K; Brown FJ; Trainor DA
Pharmacology; 1995 Jun; 50(6):388-97. PubMed ID: 7568338
[TBL] [Abstract][Full Text] [Related]
11. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.
Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U
Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776
[TBL] [Abstract][Full Text] [Related]
12. Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta.
He HM; Long CL; Zhang LZ; Fu AL; Wang H
Acta Pharmacol Sin; 2005 Jan; 26(1):69-76. PubMed ID: 15659117
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.
Metzger F; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):452-9. PubMed ID: 8897448
[TBL] [Abstract][Full Text] [Related]
14. Different potassium channels are involved in relaxation of rat renal artery induced by P1075.
Novakovic A; Pavlovic M; Milojevic P; Stojanovic I; Nenezic D; Jovic M; Ugresic N; Kanjuh V; Yang Q; He GW
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):24-30. PubMed ID: 22225832
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Löffler-Walz C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
[TBL] [Abstract][Full Text] [Related]
16. Binding and effects of P1075, an opener of ATP-sensitive K+ channels, in the aorta from streptozotocin-treated diabetic rats.
Glocker S; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):210-5. PubMed ID: 9272727
[TBL] [Abstract][Full Text] [Related]
17. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
Quast U; Villhauer EB
Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
19. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
Greenwood IA; Weston AH
Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
[TBL] [Abstract][Full Text] [Related]
20. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
Hu SL; Kim HS; Okolie P; Weiss GB
J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
